Clinical Observation of Jin's Triple-Needle Therapy Combined with Bilateral High-Frequency Repetitive Transcranial Magnetic Stimulation in the Treatment of Post-stroke Hemiplegia
10.13359/j.cnki.gzxbtcm.2025.05.017
- VernacularTitle:靳三针疗法联合双侧高频重复经颅磁刺激治疗脑卒中后偏瘫的临床观察
- Author:
Caili GAO
1
;
Chun'ai FU
;
Li GAO
;
Lei LI
;
Guojun WANG
;
Jing LIU
Author Information
1. 延安市中医医院针灸科,陕西 延安 716000
- Keywords:
stroke;
hemiplegia;
Jin's triple-needle therapy;
bilateral high-frequency repetitive transcranial magnetic stimulation;
limb motor function;
quality of life
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2025;42(5):1154-1160
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of Jin's triple-needle therapy combined with bilateral high-frequency repetitive transcranial magnetic stimulation in the treatment of post-stroke hemiplegia.Methods A total of 116 patients diagnosed with post-stroke hemiplegia and admitted to the wards and outpatient clinics of Yan'an City Hospital of Traditional Chinese Medicine from January 2023 to June 2024 were selected as the study subjects.The patients were randomly divided into an observation group and a control group using a random number table,with 58 patients in each group.The control group received bilateral high-frequency repetitive transcranial magnetic stimulation,while the observation group received Jin's triple-needle therapy in addition to the control group's treatment.After 30-day treatment,the clinical efficacy of the two groups was evaluated.Changes in traditional Chinese medicine(TCM)syndrome scores,Fugl-Meyer Assessment(FMA)scores for limb motor function,and Stroke-Specific Quality of Life(SS-QOL)scores were observed before and after treatment.Changes in neuron-specific enolase(NSE),glial fibrillary acidic protein(GFAP),and central nervous system-specific protein(S100-β)levels were compared between the two groups before and after treatment.The safety and incidence of adverse reactions in both groups were also evaluated.Results(1)The total effective rate in the observation group was 91.38%(53/58),compared to 75.86%(44/58)in the control group.The observation group showed significantly better efficacy than the control group,with a statistically significant difference(P<0.05).(2)After treatment,both groups showed significant improvements in TCM syndrome scores and FMA scores for limb motor function(P<0.05),and the observation group was significantly superior to the control group in improving TCM syndrome scores and FMA scores,with a statistically significant difference(P<0.05).(3)After treatment,both groups showed significant improvementss(P<0.05)in NSE,GFAP,and S100-β level,and the observation group was significantly superior to the control group in improving NSE,GFAP,and S100-β levels,with a statistically significant difference(P<0.05).(4)After treatment,both groups showed significant improvements in SS-QOL scores for quality of life(P<0.05),and the observation group was significantly superior to the control group in improving SS-QOL scores,with a statistically significant difference(P<0.05).(5)The incidence of adverse reactions in the observation group was 12.07%(7/58),compared to 8.62%(5/58)in the control group.There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Jin's triple-needle therapy combined with bilateral high-frequency repetitive transcranial magnetic stimulation can significantly improve clinical symptoms,enhance limb motor function,reduce levels of brain injury markers,and improve the quality of life in patients with post-stroke hemiplegia.The treatment is safe and shows significant efficacy.